Research Compliance

CBD, a non-psychoactive cannabinoid, is experiencing a massive surge in popularity, but clinical research lags behind in verifying effective uses.

We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.

If your research must comply with the revised Common Rule, you’ll need to update the way you write ICFs to meet the new requirements.

While many US researchers are aware of the coming Common Rule changes, not everyone is sure whether they will need to comply with the revised regulations.

Learn the basics of how ICH-GCP Guidelines can impact the study ICF and how we at Advarra came to our updated policy on the topic.

Please note that this material is provided for informational purposes only and not for the purpose of providing legal advice.

Clinical research continues to grow throughout the world, with researchers looking outside the US for new and diverse subject populations to help develop and improve investigational therapies. Lauri Carlile, VP of Operations at Advarra, discusses the basics of ex-US research ethics review for US-based researchers.

Learn the necessary steps to create an effective SOP for data collection in clinical trials when using an electronic data capture (EDC) system.

NIH’s policy for certificates of confidentiality changed so that CoCs are automatically issued for all NIH-funded research that uses sensitive information.

This blog outlines the principle of equitable selection and the requirement for additional safeguards for certain vulnerable groups.

Recently, the clinical research community has been making efforts to include more diverse subject populations in clinical studies.